UPDATE: Abbott (ABT) Tops Q2 EPS by 15c, Offers Guidance

Abbott (NYSE: ABT) reported Q2 EPS of $1.17, $0.15 better than the analyst estimate of $1.02. Revenue for the quarter came in at $10.2 billion versus the consensus estimate of $9.7 billion.

ABBOTT'S EARNINGS-PER-SHARE GUIDANCE:

Abbott projects 2021 diluted earnings per share from continuing operations under GAAP of $2.75 to $2.95. Abbott forecasts specified items for the full-year 2021 of $1.55 per share primarily related to intangible amortization, restructuring and cost reduction initiatives, including expenses to align its COVID-19 testing-related business with current and projected demand, expenses associated with acquisitions and other net expenses. Excluding specified items, projected adjusted diluted earnings per share from continuing operations would be $4.30 to $4.50 for full-year 2021.

(Consensus sees FY $4.36)

For earnings history and earnings-related data on Abbott (ABT) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
• Aon names interim CFO as Edmund Reese exits the firm